Skip to main content

Peer Review reports

From: Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study

Original Submission
13 Jan 2021 Submitted Original manuscript
21 Mar 2021 Reviewed Reviewer Report
24 Mar 2021 Reviewed Reviewer Report
29 Mar 2021 Author responded Author comments - Xia Wang
Resubmission - Version 2
29 Mar 2021 Submitted Manuscript version 2
1 Apr 2021 Reviewed Reviewer Report
15 Apr 2021 Reviewed Reviewer Report
19 Apr 2021 Author responded Author comments - Xia Wang
Resubmission - Version 3
19 Apr 2021 Submitted Manuscript version 3
Publishing
20 Apr 2021 Editorially accepted
30 Apr 2021 Article published 10.1186/s12885-021-08228-2

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us